Ziegler Capital Management, LLC Fibrogen Inc Transaction History

Ziegler Capital Management, LLC

  • $2.84 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 27, 2021
SELL
$10.18 - $26.64 $247,282 - $647,112
-24,291 Closed
0 $0
Q2 2021

Jul 21, 2021
BUY
$18.57 - $35.68 $125,328 - $240,804
6,749 Added 38.47%
24,291 $647,000
Q1 2021

Apr 29, 2021
BUY
$31.0 - $55.72 $543,802 - $977,440
17,542 New
17,542 $609,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Ziegler Capital Management, LLC Portfolio

Follow Ziegler Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ziegler Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email